Elliot Hershberg
Genomics researcher and investor; writes The Century of Biology on where biotechnology is actually going.
Elliot Hershberg did not write this page.
We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording. Their own site. Is this you? Claim it or ask us to remove it. Or tell us what is wrong here.
Filter All topics · Newest first
-
Our reading
AI is becoming the next major paradigm shift in biology, following genetics and genomics.
Their wordsIt's becoming more clear each day that the next chapter of this story is AI.
-
Their wordsWe are very early in the development of agentic systems in biology.
-
Their wordsIn other words, computer science has already revolutionized biological research.
- 2 months earlier
-
Our reading
Biotech R&D efficiency and pharma R&D efficiency are not the same thing and should not be conflated.
Their wordsBiotech R&D efficiency and pharma R&D efficiency are not the same thing.
↗AI Versus Eroom's Lawcenturyofbio.com 1st of 3 in this piece
-
Their wordsNew technologies can and do make an impact on R&D productivity.
↗AI Versus Eroom's Lawcenturyofbio.com 2nd of 3 in this piece
-
startupsPsychotherapyinnovation
Their wordsRelying on pharma as top-down tastemakers can stifle the emergence of new therapeutic ideas from startups.
↗AI Versus Eroom's Lawcenturyofbio.com 3rd of 3 in this piece
- 3 months earlier
-
Their wordsCancer is a disease of information. Loss of genomic information threatens to destroy the self.
↗Going Founder Mode On Cancercenturyofbio.com 1st of 3 in this piece
-
Their wordsIn recent years, China has adopted a dramatically different posture towards testing experimental medicines that now threatens the future competitiveness of the American biotech sector.
↗Going Founder Mode On Cancercenturyofbio.com 2nd of 3 in this piece
-
Our reading
Drug discovery has become less efficient over time despite continued technological progress.
Their wordsDrug discovery has gotten less efficient over time despite extraordinary technological progress.
↗Going Founder Mode On Cancercenturyofbio.com 3rd of 3 in this piece
- 8 weeks earlier
-
Their wordsBut I don't think that means there can't be massive, objectively investable infrastructure businesses that create a lot of value for the industry.
↗On AI Infrastructure in Biologycenturyofbio.com 1st of 3 in this piece
-
Their wordsIn this type of transition, it's incredibly hard for one platform company to offer every solution needed to build the next wave of applications.
↗On AI Infrastructure in Biologycenturyofbio.com 2nd of 3 in this piece
-
AI and scienceprotein structure prediction
Their wordsCompared to experiments, AI models have a few advantages: They can average out background experimental noise, incorporate priors from massive data sets like the PDB, and interpolate between nearby data points.
↗On AI Infrastructure in Biologycenturyofbio.com 3rd of 3 in this piece
- 5 months earlier
-
Their wordsMolecular biology is not like physics. The complexity-and nonlinearity-of living systems has required a brute force approach to knowledge creation and dissemination.
↗What Are Virtual Cells?centuryofbio.com 1st of 3 in this piece
-
Their wordsAfter decades of research-including lots of attempted math and software 1.0-the problem of 3D protein structure prediction was effectively solved by deep learning.
↗What Are Virtual Cells?centuryofbio.com 2nd of 3 in this piece
-
Their wordsFor human cells, with billions of DNA base pairs and tens of thousands of genes, the timeline for mechanistic whole-cell models is much less certain.
↗What Are Virtual Cells?centuryofbio.com 3rd of 3 in this piece
- 3 months earlier
-
Their wordsChina has become a serious competitive threat in biotech, demonstrating the capacity to rapidly develop new drugs that can rival-or surpass-those being produced in American labs.
↗On Modality Commoditizationcenturyofbio.com 1st of 3 in this piece
-
Their wordsno discovery technology is immune from the inescapable pull towards commoditization-like virtually every other technology.
↗On Modality Commoditizationcenturyofbio.com 2nd of 3 in this piece
-
Our reading
Revolutionary ideas eventually become universal building blocks for the next wave of innovation.
Their wordsOver time, revolutionary ideas become universal building blocks for the next wave of innovation.
↗On Modality Commoditizationcenturyofbio.com 3rd of 3 in this piece
- 4 weeks earlier
-
Their wordsWhat we haven't seen is the same type of frantic hunt for every nugget of value that could be commercialized as a result of this enormous secular trend.
↗Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com 1st of 3 in this piece
-
Their wordsThe set of diseases for which we have a molecular explanation-which resembles the equivalent of the Craigslist homepage for this analogy-has grown far faster than the corresponding set of new drugs to treat them.
↗Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com 2nd of 3 in this piece
-
Their wordsI think this partially explains some of the discontent in the scientific community about the Human Genome Project. After billions of dollars that could have been spent in other places, the result is less transformative than initially advertised.
↗Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com 3rd of 3 in this piece